ENHPATHY: Training the new generations of researchers on the molecular basic of human enhaceropathies.
1 position is available for 3-years PhD program at the University of Warsaw. Position is funded by the Marie Skłodowska-Curie Innovative Training Networks. Candidates with bioinformatics background are encouraged to apply.
ENHPATHY is a multidisciplinary science consortium created in the frame of the Marie Sklodowska-Curie actions (MSCA)-ITN-ETN European Training Networks call and regrouping 12 academic and 3 non-academic European organisations in the continuum of basic, translational and clinical research on enhancers and associated diseases.
In genetics, enhancers are short regions of DNA that can be bound by proteins to increase the likelihood that transcription of a particular gene will occur. If mutations within coding genes have traditionally been considered the major genetic cause of human disease, it is becoming increasingly clear that the genetic, structural and/or epigenetic disruption of enhancers and enhancer landscapes represent major etiological factors in numerous human diseases (i.e. enhanceropathies), ranging from rare congenital disorders to common diseases associated with ageing (e.g. cancer, diabetes). Although changes in enhancer activity are predicted to have broad pathological and therapeutic implications, there is a limited mechanistic understanding of human enhanceropathies. ENHPATHY aims to increase scientific knowledge and train the new generation of researcher on the molecular basis of human enhanceropathies to open new diagnostic and therapeutic avenues for patients.
1-Students will be employed by the host organization for the duration of their PhD.
2-They will receive a competitive salary and travel allowance.
3-They will benefit from an extensive training program in research and transferable skills.
4-As a part of an international network, they will participate in joint activities within the program (retreats, training workshops, summer schools & conferences) and visit other organizations within the ENHPATHY’s consortium.
1-Applicants can be of any nationality.
2-They must fulfill the mobility rule, i.e. have resided or carried out their main activity (work, studies, etc.) in the country of the host organization for no more than 12 months in the 3 years immediately before the recruitment date.
3-They must also fulfill the Early Stage Researchers (ESRs) rule, i.e. be within their first four years (full-time equivalent research experience) of their research careers at the date of recruitment by the host organization and have not been awarded a doctoral degree.
4-They must hold a Master’s degree (MSc) in biology, biochemistry, bioinformatics, biophysics, biotechnology, medicine or any other related discipline.
5-A high proficiency in spoken and written English is required.
1- All applications should be made using the following email: email@example.com
2- They should include a cover letter, a CV and contact information of two referees.
3- Selected candidates will be interviewed by video conference (July 2020).
4- The ESR will be selected by July 2020 and is expected to start between September and December 2020.
JOB STATUS Full-time
OFFER STARTING DATE 01/09/2020